# A Randomized Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban for Women in Spontaneous Preterm Labour

> **NCT02292771** · PHASE3 · TERMINATED · sponsor: **GlaxoSmithKline** · enrollment: 97 (actual)

## Conditions studied

- Obstetric Labour, Premature

## Interventions

- **DRUG:** Retosiban
- **DRUG:** Atosiban
- **DRUG:** Placebo matching retosiban
- **DRUG:** Placebo matching atosiban

## Key facts

- **NCT ID:** NCT02292771
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-03-16
- **Primary completion:** 2017-08-25
- **Final completion:** 2017-08-25
- **Target enrollment:** 97 (ACTUAL)
- **Why stopped:** The study was stopped due to the feasibility of recruiting the study in a timely manner
- **Last updated:** 2020-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02292771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02292771, "A Randomized Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban for Women in Spontaneous Preterm Labour". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02292771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*